Search thousands of podcasts, books, movies, and transcripts

Products

Media monitoringSentiment analysis

Blog

IMDb for PodcastsMedia Monitoring ToolsSentiment Analysis in PR and MarketingThe Evolution of Media MonitoringMastering Podcast AdvertisingAudio Market Research has been unlockedAI in Podcast Sentiment AnalysisPodcast intelligence
© 2024 Discotech BV
Privacy PolicyTerms & Conditions
    Novo Nordisk (Ozempic)

    Novo Nordisk (Ozempic)

    Acquired

    Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became too strong for us to resist. While we didn’t know much about Novo Nordisk before diving in, our first thought was, “wow, seems like these new diabetes and obesity drugs mean serious trouble for big insulin companies.”And then… we realized that Novo Nordisk IS the big insulin company. And in a story befitting of Steve Jobs and Apple, they’d just disrupted themselves with the drug equivalent of an iPhone moment. Once we dug further, we quickly realized this company has it all: an incredible 100+ year history filled with Nobel Prizes, bitter personal rivalries, board room dram
    0
    (-)
    Rate this episode:

    Episode mentions

    You can listen to this podcast, but not everything mentioned in it has been defined yet. Upvote it if you want it to be added next - the most voted podcasts will be added as soon as possible

    Transcript

    This episode has not been transcribed yet. Upvote it if you want it to be added next - the most voted podcasts will be added as soon as possible.

    Reviews

      No reviews yet, be the first!